Drug
Orelabrutinib And Placebo
Orelabrutinib And Placebo: highest development phase Phase 1, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Orelabrutinib and placebo (orelabrutinib tablet simulator) NCT05660720 | Phase 1 | Healthy Subject |
Latest
No recent events.
Follow Orelabrutinib And Placebo on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.